In response to the “Angelina Jolie Pitt: Diary of a Surgery,” Op-Ed, published in The New York Times on March 24, 2015, OCRF co-wrote a Letter to the Editor along with Ovarian Cancer National Alliance, reminding readers that there is still no early detection method for ovarian cancer. We’re grateful to once again have the opportunity to further educate and inform the public on this important health issue, and applaud Ms. Jolie Pitt for her courage in sharing her story.
Related Topics
AWS Highlights OCRA’s Research Exchange in $100 Million Health Impact Initiative
Recognition underscores the potential of OCRA’s innovative approach to accelerating gynecologic cancer research through AI, data sharing, and collaboration. Amazon Web Services (AWS) has launched its Health Impact Initiative, a $100 million, five-year commitment to putting AI, advanced computing, and cloud infrastructure in the hands of organizations working to address some of the world’s most … Continued
OCRA Names Dmitriy Zamarin, MD, PhD, as 2026 Liz Tilberis Research Prize Winner
Dmitriy Zamarin, MD, PhD, has been awarded the 2026 Liz Tilberis Research Prize for Outstanding Early Career Investigators by Ovarian Cancer Research Alliance (OCRA). A physician-scientist whose research has explored new approaches to harnessing the immune system against ovarian cancer, Dr. Zamarin is Professor of Oncology, Section Head of Gynecologic Medical Oncology, and Co-Director of … Continued
OCRA Awards 2026 Rosalind Franklin Excellence in Ovarian Cancer Research Prize to Kenneth Nephew, PhD
Ovarian Cancer Research Alliance (OCRA) has named Kenneth Nephew, PhD, as the winner of the 2026 Rosalind Franklin Excellence in Ovarian Cancer Research Prize. For more than three decades, he has helped advance the field of ovarian cancer research through both his investigations into treatment resistance and his mentorship of others studying this disease. “Dr. … Continued